Mach7 Technologies Limited (M7T) Q4 2026 Earnings Call

Investor webinar replay

Replay transcript excerpt

Good morning, everyone, and welcome to the Mark 7 Q4 FY26 result briefing. My name is Frances Dixon, and I'm Head of Investor Relations for Mark 7. Today, our CEO, Terry Thomas, and Interim CFO, Shawnee Hadsfield, will provide an overview of our Q4 result. We will then open it up for questions. If you have a question, please submit it by the Q&A text box at the bottom of the screen. I'll now hand over to Terry. Thanks, Francoise. Hi, everybody. Nice to be here. Given my propensity for bird analogies, I can't resist starting off by saying that this quarter has flown by. When you're this busy, quarters have a way of doing that. Let me give a little bit of quick context for anybody who's not familiar with Mach 7. We're a company of just over 100 people and our job is to get every medical image, whether it's x-rays or PACs, ultrasound, MRI, CT, mammography, whatever the modality, to be able to get that organized into one archive, served up very quickly through our zero footprint viewer, and then make those images even more usable through a growing set of new products. We help hospitals and imaging centers actually do something with their imaging data under the wings of our Flamingo set of products, starting with strong interoperability, some ingestion foundational components, hybrid cloud and on-prem storage, orchestration of those images, routing them appropriately, and workflow automation. So back to the quarter. Not a huge headline quarter. It's a proof point quarter. All year, I've called fiscal year 2016, The Year of a Reset, a time for us to reassess, adjust, design some improvements, and then execute. And we've done this. Better products, better revenue quality, tighter operating expenses, and more discipline across the board. We only announced this reset at Hallo...